A Phase IV, Prospective, Non-Interventional, Multicenter Study Evaluating the Efficacy and Safety of Tolvaptan in Patients with Heart Failure

Trial Profile

A Phase IV, Prospective, Non-Interventional, Multicenter Study Evaluating the Efficacy and Safety of Tolvaptan in Patients with Heart Failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2018

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SMILE
  • Most Recent Events

    • 31 Mar 2018 According to results published in the Circulation Journal, the study period was from 2011 to 2016.
    • 31 Mar 2018 Status changed from active, no longer recruiting to completed, according to results published in the Circulation Journal.
    • 31 Mar 2018 Results (n=3349) assessing the risk score to predict the prevalence of hypernatremia using the final dataset of this study, published in the Circulation Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top